SPDL1 and cancer: It is also noteworthy that in these patients, sPD-L1 concentration was also associated with a longer OS of patients, but it was evident only at selected time-points during therapy, probably due to different factors that could affect these results (e.g., cancer histotypes, timing, and doses of ICI administration).